Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Drugs (Abingdon Engl). 2019 Jan 16;27(1):69–78. doi: 10.1080/09687637.2018.1557595

Table 1.

Demographic Characteristics (n = 60).

Variable Patient at
Baseline
n=43
n (%)
Non-Patient at
Baseline
n= 17
n (%)
Total

n=60
n (%)
Age, mean (sd) 21.8 (2.50) 21.6 (2.67) 21.8 (2.53)

Gender/Sex at birth 24 (55.8) 12 (70.6) 36 (60.0)
 Male

Sexual identitya 30 (71.4) 14 (82.4) 44 (74.6)
 Heterosexual

Raceb
 Non-Hispanic White 16 (39.0) 5 (29.4) 21 (36.2)
 Non-Hispanic Black/ AfricanAmerican 8 (19.5) 1 (5.9) 9 (15.5)
 Non-Hispanic Multiracial 4 (9.8) 2 (11.8) 6 (10.3)
 Non-Hispanic Asian/Pacific Islander 1 (2.4) 1 (5.9) 2 (3.4)
 Hispanic/Latino 12 (29.3) 8 (47.1) 20 (34.5)

Education/
 Some college or above 37 (86.0) 13 (76.5) 50 (83.3)
 Currently in school/ educational program 32 (74.4) 12 (70.6) 44 (73.3)
Employed 25 (58.1) 11 (64.7) 36 (60.5)
90 Day Marijuana Use, mean (sd) 71.4 (23.63) 55.6 (31.61) 66.9 (26.84)
Emotional Regulation Questionnaire, mean (sd)
Cognitive appraisal 5.4 (1.22) 4.7 (1.82) 5.2 (1.44)
Suppression 3.5 (1.38) 3.2 (1.40) 3.4 (1.38)
Chronic Health Condition (yes) 26 (60.5) 7 (41.2) 33 (55.0)
a

1 refuse to answer for non-patient

b

2 refuse to answer for patients